ALFA Finder| Value | ₹0.85 Cr |
|---|---|
| Execution period | Expected to be completed within 30th November, 2026 |
BSE filing, NSE: KOVAI. Summary written from the filing by ALFA Finder's alert engine.
Kovai Medical Center and Hospital Ltd: key numbers
- Share price
- ₹5,949.85
- Market cap
- ₹6,510 Cr
- Revenue (annual)
- ₹1,586 Cr
- Net profit (annual)
- ₹244.5 Cr
- P/E (TTM)
- 25.8×Sector 53.9×
- Promoter holding
- 56.53%+0.01% QoQ
- FII holding
- 1.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kovai Medical Center and Hospital Ltd
All →Kovai Medical Center and Hospital Legal & Regulatory
Kovai Medical Center received a customs adjudication order for ₹2.11 Crore duty, fine and penalty. The order concerns non-fulfilment of post-importation conditions on duty-free equipment imports.
- Value
- ₹2.11 Cr
Kovai Medical Center and Hospital Board Meeting Date
Kovai Medical Center intimated BSE that its Board will meet on 11 Nov 2026 to approve unaudited results for the quarter ended 30 Sep 2026. No financial figures or other decisions are disclosed yet.
Kovai Medical Center and Hospital Other Announcement
Kovai Medical Center & Hospital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This is a routine periodic regulatory disclosure with no new transaction.
Kovai Medical Center and Hospital Promoter Buying: ₹0.19 Cr
Promoter Pavai Property Developers acquired 316 shares of Kovai Medical Center via open market purchase for ₹0.19 Crore. This increases their holding slightly.
- Value
- ₹0.19 Cr
Kovai Medical Center and Hospital Promoter Buying: ₹0.31 Cr
Promoter entity Pavai Property Developers Private Limited purchased 500 equity shares of Kovai Medical Center & Hospital Ltd via market acquisition.
- Value
- ₹0.31 Cr
Kovai Medical Center and Hospital Annual General Meeting
Kovai Medical Center shareholders approved Dr. Arun N Palaniswami's re-designation as Joint Managing Director via postal ballot. The resolution passed with 96% assent in September 2026.
Other merger & restructuring announcements
All →AAA Technologies Merger & Restructuring
AAA Technologies approved four wholly owned subsidiaries in Singapore, Mauritius, Dubai and India. Each entity is in IT security, cybersecurity and technology services.
Tirupati Starch & Chemicals Merger & Restructuring Worth ₹2.98 Cr
Tirupati Starch agreed to sell its Indore immovable property to Usha and Arpit Doshi for Rs 2.98 Crore. Completion is expected by 15 January 2027, subject to conditions.
- Value
- ₹2.98 Cr
- Execution
- Completion expected on or before 15 January 2027
CFF Fluid Control Merger & Restructuring
CFF Fluid Control will form a 51% joint venture with TKMS Atlas Elektronik for anti-submarine warfare in India. No deal value is disclosed.
Trom Industries Merger & Restructuring Worth ₹0.02 Cr
Trom Industries plans to incorporate Trom Energy SPV Private Limited, a solar power subsidiary, holding 98%. The initial cash subscription is Rs 1,96,000 for 19,600 shares.
- Value
- ₹0.02 Cr
Yasons Chemex Care Merger & Restructuring Worth ₹29.61 Cr
Yasons Chemex's subsidiary Rishit Polysurf LLP signed a slump sale agreement to sell its chemical manufacturing business to Vasudha Specialities Emulsifiers. Consideration is Rs.29.61 Crore in cash.
- Value
- ₹29.61 Cr
Dhruv Consultancy Services Merger & Restructuring Worth ₹0.3 Cr
Dhruv Consultancy incorporated Valsang Drivehub Private Limited, subscribing to 55% for Rs.0.30 Crore. The subsidiary will execute a wayside amenities project under an NHLML award.
- Value
- ₹0.30 Cr